Perceptions of Older Men Using a Mobile Health App to Monitor Lower Urinary Tract Symptoms and Tamsulosin Side Effects: Mixed Methods Study.
Perceptions of Older Men Using a Mobile Health App to Monitor Lower Urinary Tract Symptoms and Tamsulosin Side Effects: Mixed Methods Study.
复制标题
DOI：
10.2196/30767
复制
发表时间：
2021-12-24
影响因子：
2.7
通讯作者：
Bauer SR
中科院分区：
文献类型：
--
作者：
Wang EY;Breyer BN;Lee AW;Rios N;Oni-Orisan A;Steinman MA;Sim I;Kenfield SA;Bauer SR
移动的健康（mHealth）应用程序可以为患有下尿路症状（LUTS）的患者提供一种有效的方式，以记录症状和药物副作用并与他们的临床医生进行沟通。这项研究的目的是探索老年男性使用mHealth应用程序跟踪他们的症状和坦索罗辛副作用后的看法。在一项为期2周的试验性研究后进行了结构化电话访谈，该研究每天使用移动的应用程序跟踪患者选择的LUTS和坦索罗辛副作用的严重程度。考虑了定量和定性数据。所有19名（100%）试点研究参与者完成了研究后的采访。大多数男性（n=13，68%）报告称，每日问卷的长度合适，32%（n=6）报告称问卷太短。症状更严重的男性不太可能报告健康感知的变化或自我管理的变化; 47%（n=9）的男性报告症状意识改善，5%（n=1）根据问卷调整液体摄入量。所有的男性都愿意与他们的临床医生分享应用程序数据。对定性数据的专题分析产生了八个专题：（1）定向（设置应用程序、格式、症状选择和副作用选择），（2）触发器（常规或习惯和症状时间），（3）每日问卷（报告症状，报告副作用和定制），（4）技术素养，（5）感知（意识、因果关系或相关性、数据质量、便利性、有用性和其他应用程序），（6）自我管理，（7）临床医生参与（沟通和效率），和（8）改进（参考资料，灵活性，语言，管理建议，并优化临床医生参与）。我们评估了男性使用移动健康应用程序来监测和改善LUTS和药物副作用的管理的看法。通过定制移动的应用程序体验以满足患者的个性化需求，可以进一步优化LUTS管理，例如跟踪更多数量的症状并将应用程序与临床医生的访问整合。mHealth应用程序可能是一种可扩展的模式，用于监测症状并改善对患有LUTS的老年男性的护理。需要进一步的研究来确定定制移动的应用程序的最佳方法，并将数据传达给临床医生或将数据有意义地纳入电子病历。
Mobile health (mHealth) apps may provide an efficient way for patients with lower urinary tract symptoms (LUTS) to log and communicate symptoms and medication side effects with their clinicians. The aim of this study was to explore the perceptions of older men with LUTS after using an mHealth app to track their symptoms and tamsulosin side effects. Structured phone interviews were conducted after a 2-week study piloting the daily use of a mobile app to track the severity of patient-selected LUTS and tamsulosin side effects. Quantitative and qualitative data were considered. All 19 (100%) pilot study participants completed the poststudy interviews. Most of the men (n=13, 68%) reported that the daily questionnaires were the right length, with 32% (n=6) reporting that the questionnaires were too short. Men with more severe symptoms were less likely to report changes in perception of health or changes in self-management; 47% (n=9) of the men reported improved awareness of symptoms and 5% (n=1) adjusted fluid intake based on the questionnaire. All of the men were willing to share app data with their clinicians. Thematic analysis of qualitative data yielded eight themes: (1) orientation (setting up app, format, symptom selection, and side-effect selection), (2) triggers (routine or habit and symptom timing), (3) daily questionnaire (reporting symptoms, reporting side effects, and tailoring), (4) technology literacy, (5) perceptions (awareness, causation or relevance, data quality, convenience, usefulness, and other apps), (6) self-management, (7) clinician engagement (communication and efficiency), and (8) improvement (reference materials, flexibility, language, management recommendations, and optimize clinician engagement). We assessed the perceptions of men using an mHealth app to monitor and improve management of LUTS and medication side effects. LUTS management may be further optimized by tailoring the mobile app experience to meet patients’ individual needs, such as tracking a greater number of symptoms and integrating the app with clinicians’ visits. mHealth apps are likely a scalable modality to monitor symptoms and improve care of older men with LUTS. Further study is required to determine the best ways to tailor the mobile app and to communicate data to clinicians or incorporate data into the electronical medical record meaningfully.